Among the 3,956 T2DM patients without stroke, 2,702 (68.30%) patients used antihypertensive drugs, 562 (14.21%) patients used lipid-lowering drugs, 1,021 (25.81%) patients used aspirin, and 674 (17.04%) patients used insulin. The gene discussed is INS; the disease is stroke disorder.